Acute side effects of radiation therapy : a guide to management /
Saved in:
Author / Creator: | Sourati, Ainaz, author. |
---|---|
Imprint: | Cham : Springer, 2017. |
Description: | 1 online resource |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11308004 |
Table of Contents:
- Foreword; Introduction; 1: Radiation Dermatitis; 1.1 Mechanism; 1.2 Timing; 1.3 Sign and Symptoms; 1.4 Scoring; 1.5 Risk Factors; 1.5.1 Treatment-Related Factors Including; 1.5.2 Patient-Related Factors Include; 1.6 Diagnosis; 1.7 Prevention; 1.7.1 General Measures; 1.7.2 Intensity-Modulated Radiation Therapy (IMRT); 1.7.3 Low-Level Laser Therapy; 1.7.4 Amifostine; 1.7.5 Ascorbic Acid; 1.7.6 Oral Zinc; 1.7.7 Silver Leaf Dressing; 1.7.8 MAS065D; 1.7.9 Soft Dressing or Barrier Film; 1.7.10 Hyaluronic Acid; 1.7.11 Trolamine; 1.7.12 Topical Sucralfate; 1.7.13 Theta Cream.
- 1.7.14 Dexpanthenol (Provitamin B5)1.7.15 Calendula; 1.7.16 Pentoxifylline; 1.7.17 Aloe Vera; 1.7.18 Deodorant; 1.7.19 Laughter Therapy; 1.8 Management; 1.8.1 Grade 1 Dermatitis; 1.8.2 Grade 2-3 Dermatitis; 1.8.3 Grade 4 Dermatitis; References; 2: Hair Loss; 2.1 Mechanism; 2.2 Timing; 2.2.1 Risk Factors; 2.2.2 Symptoms; 2.3 Scoring; 2.4 Prevention; 2.5 Management; References; 3: Radiation Brain Injury; 3.1 Mechanism; 3.2 Timing; 3.3 Risk Factors; 3.3.1 Treatment-Related Factors; 3.3.2 Patient-Related Factor; 3.4 Symptoms; 3.5 Diagnosis; 3.6 Scoring.
- 3.7 Prevention and Management3.7.1 Dexamethasone Prescription; References; 4: Radiation Orbital Toxicity; 4.1 Blepharitis and Eyelid Dermatitis; 4.2 Eyelash Loss; 4.3 Conjunctivitis; 4.4 Xerophthalmia; 4.5 Corneal Toxicity; 4.5.1 Treatment; 4.5.1.1 Topical Lubricants (e.g., Ophthalmic Ointment); 4.5.1.2 Analgesics; 4.5.1.3 Ophthalmologist Consult; 4.6 Iris Toxicity; References; 5: Ear Toxicity; 5.1 Mechanism; 5.2 Timing; 5.3 Risk Factors; 5.4 Symptoms and Diagnosis; 5.5 Scoring; 5.6 Management; References; 6: Oral Mucositis; 6.1 Mechanism; 6.2 Timing; 6.3 Risk Factors.
- 6.3.1 Tumor Site6.3.2 Concomitant Systemic Therapy; 6.3.3 Radiation Dose; 6.3.4 Radiation Fractionation Schedule; 6.3.5 Patient-Related Factors; 6.4 Symptoms; 6.5 Scoring; 6.6 Prevention; 6.6.1 Prophylactic Interventions; 6.6.2 Prophylactic Intervention Under Evaluation; 6.7 Management; 6.7.1 Patient Assessment; 6.7.2 Mouth Care; 6.7.3 Management of Oral Pain; 6.7.3.1 Benzydamine Mouth Wash; 6.7.3.2 Doxepin; 6.7.3.3 Magic Mouthwash; 6.7.3.4 Gelclair; 6.7.3.5 CAM2028; 6.7.3.6 MF 5232; 6.7.3.7 Acetylcysteine; 6.7.3.8 Opiates; 6.7.3.9 Corticosteroids; 6.7.3.10 Gabapentin.
- 6.7.3.11 Other Analgesic Agents6.7.3.12 Sucralfate; 6.7.3.13 Phenytoin Mouthwash; 6.7.3.14 Low-Level Laser Therapy; 6.7.4 Antifungals; 6.7.5 Antivirals; 6.7.6 Feeding Tube/Nutritional Support; References; 7: Xerostomia; 7.1 Mechanism; 7.2 Timing; 7.3 Risk Factors; 7.4 Symptoms; 7.5 Diagnosis; 7.6 Scoring; 7.7 Prevention; 7.7.1 Amifostin; 7.7.1.1 Prescription; 7.7.1.2 Contraindications; 7.7.1.3 Advers effects; 7.7.2 IMRT; 7.7.3 Submandibular gland transfer; 7.7.4 Pilocarpine; 7.7.4.1 Prescription; 7.7.4.2 Contraindications; 7.7.5 Acupuncture; 7.8 Management.